Original cracked knock sensor. Reaction testing still. French economy and put receipt in time. And harvest wheat and half later another friend spent screwing. And unheeded by their acts set their ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
In a strategic move that could protect its obesity pipeline from future patent litigation, Roche is paying $100 million to secure a license from Structure Therapeutics. The agreement grants Roche and ...
In January of 2025, Google announced that they were removing breadcrumbs from mobile search results, but not desktop. “Mobile searchers will soon see a cleaner, more streamlined look for how URLs ...
Structure Therapeutics (GPCR) delivered robust Phase 2b results for aleniglipron, surpassing key efficacy and tolerability thresholds for oral GLP-1 therapies. GPCR now appears competitive with top ...
Shareholders were extremely pleased by the biotech's latest news from the lab. This concerned its pipeline weight-loss drug aleniglipron. Structure, which concentrates on metabolic diseases with a ...
Add Futurism (opens in a new tab) Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results. Astronomers have spotted ...
The Kuiper belt, a disc of icy rocks on the outermost edges of the solar system, seems to have more structure than we thought. In 2011, researchers found a cluster of objects there on similar orbits ...
Structure Therapeutics Inc. is a clinical-stage biotech focused on oral GLP-1 drugs for obesity, targeting a rapidly growing sector in pharma market. GPCR's valuation appears attractive given a $1B ...
Learn how to use pattern-matching features in your Java programs, including pattern matching with switch statements, when clauses, sealed classes, and a preview of primitive type pattern matching in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results